IFM Therapeutics launches new spinout aimed at Parkinson's, lupus and other diseases

Boston biotech IFM Therapeutic, LLC is taking a second major step out from drug giant Bristol-Myers Squibb's wake this week, spinning out its second subsidiary focused on developing treatments for autoimmune and central nervous system diseases.